Neurocrine Biosciences In... (NBIX)
NASDAQ: NBIX
· Real-Time Price · USD
141.25
-2.92 (-2.03%)
At close: Sep 10, 2025, 3:59 PM
141.25
0.00%
After-hours: Sep 10, 2025, 04:54 PM EDT
Neurocrine Biosciences Stock Forecast
Stock Price Forecast
The 18 analysts with 12-month price forecasts for NBIX stock have an median target of 164, with a low estimate of 139 and a high estimate of 185. The median target predicts an increase of 16.11% from the current stock price of 141.25.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 139 | 163.72 | 164 | 185 |
| Change | -1.59% | 15.91% | 16.11% | 30.97% |
Latest Analyst Insight Report
RBC Capital retains an Outperform rating on Neuroc... Unlock content with Pro Subscription
Updated Jul 31, 2025
| Rating | Apr 25 | May 25 | Jun 25 | Jul 25 | Aug 25 | Sep 25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 4 | 0 | 2 | 1 | 0 |
| Buy | 6 | 2 | 1 | 7 | 0 | 2 |
| Hold | 0 | 1 | 0 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 1 | 10 | 1 | 2 |
Financial Forecast this Year
Revenue This Year
2.79B
from 2.36B
Increased by 18.4%
Revenue Next Year
3.2B
from 2.79B
Increased by 14.8%
EPS This Year
4.44
from 3.4
Increased by 30.6%
EPS Next Year
6.49
from 4.44
Increased by 46.2%